New research by scientists at Cedars-Sinai's Maxine Dunitz Neurosurgical Institute suggests that a drug currently approved to treat erectile dysfunction may significantly enhance the delivery of the anti-cancer drug Herceptin to certain hard-to-treat brain tumors. The research, published in the current issue of the journal PLoS ONE, could help doctors improve treatments for lung and breast cancers that have metastasized to the brain...
More...
More...